Palatin Technologies Inc. (PTN)

[apollo1452]

On 8/18/15 the FDA approved Sprout Pharma's Addyi for women's Hypoactive Sexual Desire Disorder (HSDD). On 8/20/15 Valeant Pharma (now Bausch Health Cos) bought Sprout Pharma for $1 BILLION in cash, plus a share of future profits based upon certain milestones.

Addyi is a terrible drug. The FDA requires a Boxed Warning regarding risk of severe low blood pressure & fainting. Addyi CANNOT be used with alcohol & Requires Daily Dosage to work. Addyi has numerous side effects including dizziness, sleep disorders, nausea, tiredness, dry mouth. Addyi does not work on men.

And the kicker: " Do not drink grapefruit juice if you take Addyi. Drinking grapefruit juice during your treatment with Addyi increases your risk of loss of consciousness." SMH!

ALL THAT B.S. FOR $1 BILLION PLUS??? Compare to Vyleesi which is only taken on demand when sex is desired, is good with alcohol & has minimal side effects...& Vyleesi Works On Men.

IMO PTN bidding war starts at $1 BILLION PLUS PLUS with Vyleesi approval.